Population-Based Screening for BRCA1 and BRCA2 2014 Lasker Award

被引：218
|
作者：
King, Mary-Claire [1 ]
Levy-Lahad, Ephrat [2 ,3 ]
Lahad, Amnon [3 ,4 ]
机构：
[1] Univ Washington, Dept Med & Genome Sci, Seattle, WA 98195 USA
[2] Shaare Zedek Med Ctr, Inst Med Genet, Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
[4] Clalit Hlth Serv, Dept Family Med, Jerusalem, Israel
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2014年 / 312卷 / 11期
关键词：
CANCER-RISK;
D O I：
10.1001/jama.2014.12483
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1091 / 1092
页数：2
相关论文
共 50 条
  • [31] Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases
    Ponder, BAJ
    Day, NE
    Easton, DF
    Pharoah, PDP
    Lipscombe, JM
    Redman, K
    Antoniou, A
    Basham, V
    Gregory, J
    Gayther, S
    Dunning, A
    BRITISH JOURNAL OF CANCER, 2000, 83 (10) : 1301 - 1308
  • [32] A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer
    Lu, KH
    Cramer, DW
    Muto, MG
    Li, EY
    Niloff, J
    Mok, SC
    OBSTETRICS AND GYNECOLOGY, 1999, 93 (01): : 34 - 37
  • [33] BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland:: a population-based study
    Rafnar, T
    Benediktsdottir, KR
    Eldon, BJ
    Gestsson, T
    Saemundsson, H
    Olafsson, K
    Salvarsdottir, A
    Steingrimsson, E
    Thorlacius, S
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (18) : 2788 - 2793
  • [34] Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience
    Lieberman, Sari
    Lahad, Amnon
    Tomer, Ariela
    Cohen, Carmit
    Levy-Lahad, Ephrat
    Raz, Aviad
    GENETICS IN MEDICINE, 2017, 19 (06) : 628 - 634
  • [35] Identification of BRCA1/BRCA2 carriers by screening in the healthy population and its implications.
    Levy-Lahad, E.
    Gabai-Kapara, E.
    Kaufman, B.
    Catane, R.
    Segev, S.
    Renbaum, P.
    Beller, U.
    King, M.
    Lahad, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Screening and Clinical Implications for BRCA1 and BRCA2 Mutation Carriers
    Sharon E. Plon
    Journal of Mammary Gland Biology and Neoplasia, 1998, 3 : 377 - 387
  • [37] Screening and clinical implications for BRCA1 and BRCA2 mutation carriers
    Plon, SE
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1998, 3 (04) : 377 - 387
  • [38] Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
    McKinley, Joanne M.
    Weideman, Prue C.
    Jenkins, Mark A.
    Friedlander, Michael L.
    Hopper, John L.
    McLachlan, Sue-Anne
    Lindeman, Geoffrey J.
    Phillips, Kelly-Anne
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2007, 5 (03) : 161 - 163
  • [39] Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
    Warner, Ellen
    CANCERS, 2018, 10 (12)
  • [40] Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
    Joanne M McKinley
    Prue C Weideman
    Mark A Jenkins
    Michael L Friedlander
    John L Hopper
    Sue-Anne McLachlan
    Geoffrey J Lindeman
    kConFab Investigators
    Kelly-Anne Phillips
    Hereditary Cancer in Clinical Practice, 5
12345